Article
A Machine Learning Approach Predicts Tissue-Specific Drug Adverse Events
2018-03-24
Abstract excerpt
<h4>ABSTRACT</h4> One of the main causes for failure in the drug development pipeline or withdrawal post approval is the unexpected occurrence of severe drug adverse events. Even though such events should be detected by in vitro, in vivo, and human trials, they continue to unexpectedly arise at different stages of drug development causing costly clinical trial failures and market withdrawal. Inspired by the “mone...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7882aea8-ca6d-5445-9b14-772b633ee9ea
- DOI
- 10.1101/288332
